Clorox (NYSE:CLX) PT Raised to $135.00 at JPMorgan Chase & Co.

Clorox (NYSE:CLXGet Rating) had its target price upped by investment analysts at JPMorgan Chase & Co. from $126.00 to $135.00 in a note issued to investors on Friday, The Fly reports. The firm currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential downside of 7.60% from the company’s previous close.

Several other research analysts have also weighed in on CLX. UBS Group boosted their price target on Clorox from $119.00 to $129.00 and gave the stock a “sell” rating in a research report on Wednesday, November 2nd. DA Davidson boosted their price target on Clorox from $124.00 to $155.00 and gave the stock a “neutral” rating in a research report on Wednesday, November 2nd. Deutsche Bank Aktiengesellschaft boosted their price target on Clorox from $148.00 to $151.00 and gave the stock a “hold” rating in a research report on Tuesday, December 6th. StockNews.com assumed coverage on Clorox in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. Finally, Morgan Stanley boosted their price target on Clorox from $130.00 to $142.00 and gave the stock an “equal weight” rating in a research report on Wednesday, November 2nd. Nine investment analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Clorox has an average rating of “Reduce” and a consensus price target of $136.92.

Clorox Trading Up 2.3 %

NYSE:CLX opened at $146.11 on Friday. The stock has a market capitalization of $18.03 billion, a PE ratio of 44.82, a price-to-earnings-growth ratio of 2.99 and a beta of 0.31. The business’s 50-day simple moving average is $145.45 and its 200-day simple moving average is $143.11. The company has a debt-to-equity ratio of 4.99, a current ratio of 0.88 and a quick ratio of 0.50. Clorox has a fifty-two week low of $120.50 and a fifty-two week high of $186.86.

Clorox (NYSE:CLXGet Rating) last released its earnings results on Tuesday, November 1st. The company reported $0.93 EPS for the quarter, beating the consensus estimate of $0.73 by $0.20. The firm had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.69 billion. Clorox had a return on equity of 83.00% and a net margin of 5.75%. Sell-side analysts expect that Clorox will post 4.11 earnings per share for the current fiscal year.

Institutional Trading of Clorox

Several large investors have recently modified their holdings of CLX. Hallmark Capital Management Inc. acquired a new stake in shares of Clorox during the 3rd quarter worth $29,000. Heritage Financial Services LLC acquired a new stake in Clorox in the second quarter valued at about $30,000. Carolinas Wealth Consulting LLC boosted its stake in Clorox by 10,476.2% in the second quarter. Carolinas Wealth Consulting LLC now owns 13,749 shares of the company’s stock valued at $30,000 after buying an additional 13,619 shares in the last quarter. Curi Wealth Management LLC boosted its stake in Clorox by 64.5% in the second quarter. Curi Wealth Management LLC now owns 227 shares of the company’s stock valued at $32,000 after buying an additional 89 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV boosted its stake in Clorox by 65.8% in the third quarter. Massmutual Trust Co. FSB ADV now owns 252 shares of the company’s stock valued at $32,000 after buying an additional 100 shares in the last quarter. 79.12% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Further Reading

The Fly logo

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.